We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Strength Seen in Elevance Health (ELV): Can Its 3.1% Jump Turn into More Strength?
Read MoreHide Full Article
Elevance Health (ELV - Free Report) shares soared 3.1% in the last trading session to close at $422.04. The move was backed by solid volume with far more shares changing hands than in a normal session. This compares to the stock's 3.4% gain over the past four weeks.
Elevance Health rallied for the sixth straight day, driven by optimism around its operations. The reaffirmed earnings forecast and medical enrollments boosted investor confidence, while multiple analyst updates with higher price targets added fuel to the momentum.
This health insurer is expected to post quarterly earnings of $10.58 per share in its upcoming report, which represents a year-over-year change of -0.6%. Revenues are expected to be $45.74 billion, up 8.2% from the year-ago quarter.
While earnings and revenue growth expectations are important in evaluating the potential strength in a stock, empirical research shows a strong correlation between trends in earnings estimate revisions and near-term stock price movements.
For Elevance Health, the consensus EPS estimate for the quarter has been revised marginally higher over the last 30 days to the current level. And a positive trend in earnings estimate revision usually translates into price appreciation. So, make sure to keep an eye on ELV going forward to see if this recent jump can turn into more strength down the road.
Elevance Health is a member of the Zacks Medical Services industry. One other stock in the same industry, Sotera Health Company (SHC - Free Report) , finished the last trading session 3.6% lower at $11.38. SHC has returned -14.9% over the past month.
Sotera Health's consensus EPS estimate for the upcoming report has changed -16.2% over the past month to $0.12. Compared to the company's year-ago EPS, this represents a change of -7.7%. Sotera Health currently boasts a Zacks Rank of #4 (Sell).
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Strength Seen in Elevance Health (ELV): Can Its 3.1% Jump Turn into More Strength?
Elevance Health (ELV - Free Report) shares soared 3.1% in the last trading session to close at $422.04. The move was backed by solid volume with far more shares changing hands than in a normal session. This compares to the stock's 3.4% gain over the past four weeks.
Elevance Health rallied for the sixth straight day, driven by optimism around its operations. The reaffirmed earnings forecast and medical enrollments boosted investor confidence, while multiple analyst updates with higher price targets added fuel to the momentum.
This health insurer is expected to post quarterly earnings of $10.58 per share in its upcoming report, which represents a year-over-year change of -0.6%. Revenues are expected to be $45.74 billion, up 8.2% from the year-ago quarter.
While earnings and revenue growth expectations are important in evaluating the potential strength in a stock, empirical research shows a strong correlation between trends in earnings estimate revisions and near-term stock price movements.
For Elevance Health, the consensus EPS estimate for the quarter has been revised marginally higher over the last 30 days to the current level. And a positive trend in earnings estimate revision usually translates into price appreciation. So, make sure to keep an eye on ELV going forward to see if this recent jump can turn into more strength down the road.
The stock currently carries a Zacks Rank #3 (Hold). You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>
Elevance Health is a member of the Zacks Medical Services industry. One other stock in the same industry, Sotera Health Company (SHC - Free Report) , finished the last trading session 3.6% lower at $11.38. SHC has returned -14.9% over the past month.
Sotera Health's consensus EPS estimate for the upcoming report has changed -16.2% over the past month to $0.12. Compared to the company's year-ago EPS, this represents a change of -7.7%. Sotera Health currently boasts a Zacks Rank of #4 (Sell).